Class ITerminatedF-1523-2013
Supplement recall · June 19, 2013
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function recall
Why: Undeclared Soy and Milk on the label.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
- Lots / codes
All SKUs
- Quantity
- 16,268 units
- Company
- Atlantic Pro Nutrients, Inc. dba XYMOGEN, Orlando, FL
- Distribution
- AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia and Hawaii
- Initiated
- May 1, 2013 · Voluntary: Firm initiated
- Classified
- June 11, 2013
- Reported
- June 19, 2013
- Ended
- January 15, 2014
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.